Variant angina and coronary artery spasm: The clinical spectrum, pathophysiology, and management

Journal of Nippon Medical School

Volumn 78, Issue 1, 2011, Pages 4-12

  Kusama, Yoshiki ^a,b   Kodani, Eitaro ^a,b   Nakagomi, Akihiro ^a,b   Otsuka, Toshiaki ^a   Atarashi, Hirotsugu ^a,b   Kishida, Hiroshi ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Coronary artery spasm; Variant angina

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ARYLDIALKYLPHOSPHATASE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NICORANDIL; NIFEDIPINE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; RHO KINASE; RHO KINASE INHIBITOR; VERAPAMIL;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ATRIOVENTRICULAR BLOCK; CAUCASIAN; CHRONIC INFLAMMATION; CIRCADIAN RHYTHM; CORONARY ARTERY SPASM; DNA POLYMORPHISM; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAGNESIUM DEFICIENCY; OXIDATIVE STRESS; PATHOGENESIS; RACE DIFFERENCE; REVIEW; SMOOTH MUSCLE CONTRACTILITY; ST SEGMENT ELEVATION; SUDDEN DEATH; SYNCOPE; THORAX PAIN; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS, VARIANT; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; CORONARY VASOSPASM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; HUMANS; NICORANDIL; NITRATES;

EID: 79951933194     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.78.4     Document Type: Review

References (52)

1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N: Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959; 27: 375-388.
2. Higgins CB, Wexler L, Silverman JF, Schroeder JS: Clinical and arteriographic features of Prinzmetal's variant angina: documentation of etiologic factors. Am J Cardiol 1976; 37: 831-839.
3. Curry RC Jr, Pepine CJ, Sabom MB, Conti CR: Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 1979; 59: 307-312. (Pubitemid 9138726)
4. Kishida H, Tada Y, Fukuma N, et al.: Significant characteristics of variant angina patients with associated syncope. Jpn Heart J 1996; 37: 317-326. (Pubitemid 26231959)
5. Yasue H, Kugiyama K: Coronary spasm: clinical features and pathogenesis. Intern Med 1997; 36: 760-765. (Pubitemid 128521681)
6. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y: Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment J Cardiol 2008; 51: 2-17.
7. Kishida H, Otsu F, Suzuki K, et al.: Prominent negative U wave in variant angina pectoris. Jpn Heart J 1985; 26: 885-896. (Pubitemid 16128740)
8. JCS Joint Working Group: Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J 2010; 74: 1745-1762.
9. Yasue H, Horio Y, Nakamura N, et al.: Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963. (Pubitemid 17174941)
10. Schroeder JS, Bolen JL, Quint RA, et al.: Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am J Cardiol 1977; 40: 487-491. (Pubitemid 8219295)
11. Shimokawa H: Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 2000; 64: 1-12.
12. Murad F: Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006; 355: 2003-2011.
13. Kugiyama K, Yasue H, Okumura K, et al.: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
14. Kugiyama K, Ohgushi M, Motoyama T, et al.: Nitric oxide-mediated flow- dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1997; 30: 920-926. (Pubitemid 27435882)
15. Kimura K, Ito M, Amano M, et al.: Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245-248. (Pubitemid 26285892)
16. Shimokawa H, Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767-1775. (Pubitemid 41243442)
17. Shimokawa H, Seto M, Katsumata N, et al.: Rhokinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999; 43: 1029-1039. (Pubitemid 29413201)
18. Katsumata N, Shimokawa H, Seto M, et al.: Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1[beta]. Circulation 1997; 96: 4357-4363. (Pubitemid 28007466)
19. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A: Suppression of coronary artery spasm by a Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547. (Pubitemid 34297629)
20. Otsuka T, Ibuki C, Suzuki T, et al.: Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina. Coron Artery Dis 2008; 19: 105-110. (Pubitemid 351317374)
21. Miwa K, Fujita M, Sasayama S: Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm. Heart Vessels 2005; 20: 1-7. (Pubitemid 40260299)
22. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S: Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974; 50: 534-539.
23. Miwa K, Igawa A, Miyagi Y, Nakagawa K, Inoue H: Alterations of autonomic nervous activity preceding nocturnal variant angina: sympathetic augmentation with parasympathetic impairment. Am Heart J 1998; 135: 762-771. (Pubitemid 28237299)
24. Saitoh T, Kishida H, Hanashi A, et al.: Coronary hyperreactivity to adrenergic stimulation and increased nocturnal vagal tone trigger coronary vasospasm. Jpn Circ J 1998; 62: 721-726.
25. Miyamoto S, Kawano H, Sakamoto T, et al.: Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal 2004; 6: 75-80. (Pubitemid 38063977)
26. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H: Vitamin E deficiency in variant angina. Circulation 1996; 94: 14-18. (Pubitemid 126426394)
27. Sugiishi M, Takatsu F: Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-79. (Pubitemid 23019336)
28. Ota Y, Kugiyama K, Sugiyama S, et al.: Impairment of endothelium- dependent relaxation of rabbit aortas by cigarette smoke extract - role of free radicals and attenuation by captopril. Atherosclerosis 1997; 131: 195-202. (Pubitemid 27232441)
29. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H: Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078. (Pubitemid 46998022)
30. Goto K, Yasue H, Okumura K, et al.: Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 1990; 65: 709-712. (Pubitemid 20093390)
31. Miwa K, Igawa A, Miyagi Y, Fujita M: Importance of magnesium deficiency in alcohol-induced variant angina. Am J Cardiol 1994; 73: 813-816. (Pubitemid 24128894)
32. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S: Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 1989; 79: 597-602. (Pubitemid 19087711)
33. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G: The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000; 118: 1690-1695. (Pubitemid 32001797)
34. Takizawa A, Yasue H, Omote S, et al.: Variant angina induced by alcohol ingestion. Am Heart J 1984; 107: 25-27. (Pubitemid 14219160)
35. Pristipino C, Beltrame JF, Finocchiaro ML, et al.: Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108. (Pubitemid 30146610)
36. Yoshimura M, Yasue H, Nakayama M, et al.: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69. (Pubitemid 28398388)
37. Nakayama M, Yasue H, Yoshimura M, et al.: T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870. (Pubitemid 29258973)
38. -786→C and missense Glu298Asp variants. J Investig Med 2000; 48: 367-374.
39. Ito T, Yasue H, Yoshimura M, et al.: Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 2002; 110: 89-94. (Pubitemid 36067423)
40. Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K: Enhanced activity of variant phospholipase C-δ1 protein (R257H) detected in patients with coronary artery spasm. Circulation 2002; 105: 2024-2029. (Pubitemid 34465263)
41. Murase Y, Yamada Y, Hirashiki A, et al.: Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004; 25: 970-977. (Pubitemid 38857871)
42. Nakamura M, Takeshita A, Nose Y: Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987; 75: 1110-1116. (Pubitemid 17081016)
43. Kishida H, Tada Y, Tetsuoh Y, et al.: A new strategy for the reduction of acute myocardial infarction in variant angina. Am Heart J 1991; 122: 1554-1561.
44. Kimura E, Kishida H: Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan. Circulation 1981; 63: 844-848. (Pubitemid 11146898)
45. Yasue H, Takizawa A, Nagao M, et al.: Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
46. Io K, Minatoguchi S, Nishigaki K, et al.: Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Arzneimittelforschung 2007; 57: 573-581.
47. Fukumoto Y, Yasuda S, Ito A, Shimokawa H: Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine. J Cardiovasc Pharmacol 2008; 51: 253-257. (Pubitemid 351450603)
48. Kishida H, Murao S: Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris. Clin Pharmacol Ther 1987; 42: 166-174. (Pubitemid 17135972)
49. Motoyama T, Kawano H, Kugiyama K, et al.: Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 1672-1679. (Pubitemid 28545207)
50. Yasue H, Mizuno Y, Harada E, et al.; SCAST (Statin and Coronary Artery Spasm Trial) Investigators: Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51: 1742-1748. (Pubitemid 351608498)
51. Ito A, Fukumoto Y, Shimokawa H: Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480-485. (Pubitemid 39305090)
52. Study of the role of coronary spasm in ischemic heart disease, supported by grants for studies on cardiovascular diseases from the Ministry of Health, Labour, and Welfare (MHLW) (10ko-5). Research report in 2000 (in Japanese).